nach oben

International Journal of Mental Health and Addiction

Erschienen in:

01.01.2007

Are the Effects of Gambling Treatment Overestimated?

verfasst von: James R. Westphal

Erschienen in: International Journal of Mental Health and Addiction | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Studies of clinical trials across the field of healthcare found use of designs that overestimate treatment effects.

Objective

review clinical trial designs used to develop gambling treatment evidence base for suitability to assess cause and effect and to accurately assess treatment effects.

Methods

literature review, grading of evidence, proportions and confidence limits

Results

The majority of published studies on gambling treatment are methodologically unsuited to determine treatment effects. Suitable (randomized and controlled) trails often use designs that can overestimate treatment effects. Attrition in published studies of gambling treatment is substantial, ranging from 11 to 83%. If attrition is not included in the analysis, overestimation of treatment effects may be similar in magnitude.

Conclusions

The current evidence may overestimate gambling treatment effects. The inclusion of intention to treat analysis, careful blinding, more equivalent control groups and measures of adherence to treatment would improve problem gambling treatment clinical trial design.

Baekeland, F., & Lundwall, L. (1975). Dropping out of treatment: A critical review. Psychological Bulletin, 82(5), 738–783 (Sep.).PubMedCrossRef

Blaszczynski, A., & Silove, D. (1995). Cognitive and behavioral therapies of pathological gambling. Journal of Gambling Studies, 11, 195–219.CrossRef

Boutron, I., Tubach, F., Giraudeau, B., & Ravaud, P. (2004). Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials. Journal Of Clinical Epidemiology, 57(6), 543–550 (Jun.).CrossRef

Brody, H. (2000). The placebo response. Recent research and implications for family medicine. Journal of Family Practice, 49(7), 649–654 (Jul.).PubMed

Carey, T. S., & Boden, S. D. (2003). A critical guide to case series reports. Spine, 28(15), 1631–1634 (Aug. 1).PubMedCrossRef

Chambless, D. L., & Ollendick, T. H. (2001). Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology, 52, 685–716.PubMedCrossRef

Coronary Drug Project Research Group (1980). Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. New England Journal of Medicine, 303(18), 1038–1041 (Oct. 30).CrossRef

Crockford, D. N, & el-Guebaly, N. (1998). Psychiatric comorbidity in pathological gambling: A critical review. Canadian Journal of Psychiatry, 43(1), 43–50.

Davidson, K. W., Goldstein, M., Kaplan, R. M., Kaufmann, P. G., Knatterud, G. L., Orleans, C. T., et al. (2003) Evidence-based behavioral medicine: what is it and how do we achieve it? Annals of Behavioral Medicine, 26(3), 161–171 (Dec.).PubMedCrossRef

Deeks, J. J., Dinnes, J., D’Amico, R., Sowden, A. J., Sakarovitch, C., Song, F., International Stroke Trial Collaborative Group; European Carotid Surgery Trial Collaborative Group et al. (2003). Evaluating non-randomised intervention studies. Health Technology Assessment, 7(27), iii–x, 1–173.

Delgado-Rodriguez, M., & Llorca, J. (2004). Bias. Journal of Epidemiology and Community Health, 58(8), 635–641 (Aug.).PubMedCrossRef

Dickerson, M., Hinchy, J., & England, S. L. (1990) Minimal treatments and problem gamblers: A preliminary investigation. Journal of Gambling Studies, 6(1), 87–101.CrossRef

Djulbegovic, B., Cantor, A., & Clarke, M. (2003). The importance of preservation of the ethical principle of equipoise in the design of clinical trials: Relative impact of the methodological quality domains on the treatment effect in randomized controlled trials. Accountability in Research, 10(4), 301–315 (Oct.–Dec.).PubMed

Doig, G. S., & Simpson, F. (2005). Randomization and allocation concealment: A practical guide for researchers. Journal of Critical Care, 20(2), 187–191; discussion 191–193 (Jun.).PubMedCrossRef

Echeburua, E., Baez, C., & Fernandez-Montalvo, J. (1996). Comparative effectiveness of three therapeutic modalities in the psychological treatment of pathological gambling. Behavioral and Cognitive Psychotherapy, 24, 51–72.CrossRef

Edlund, M. J., Wang, P. S., Berglund, P. A., Katz, S. J., Lin, E., & Kessler, R. C. (2002). Dropping out of mental health treatment: Patterns and predictors among epidemiological survey respondents in the United States and Ontario. American Journal of Psychiatry, 159(5), 845–851 (May).PubMedCrossRef

Evans, L., & Delfabbro, P. H. (2005). Motivators for change and barriers to help-seeking in Australian problem gamblers. Journal of Gambling Studies, 21(2), 133–155 (Summer).PubMedCrossRef

Fergusson, D., Glass, K. C., Waring, D., & Shapiro, S. (2004). Turning a blind eye: The success of blinding reported in a random sample of randomised, placebo controlled trials. British Medical Journal, 328(7437), 432. Epub 2004 (Jan. 22 & Feb. 21).PubMedCrossRef

Goldberg, R. J., Leigh, H., & Quinlan, D. (1979) The current status of placebo in hospital practice. General Hospital Psychiatry, 1(3), 196–201 (Sep.).PubMedCrossRef

Grant, J. E., Kim, S. W., & Kuskowski, M. (2004). Retrospective review of treatment retention in pathological gambling. Comprehensive Psychiatry, 45(2), 83–87 (Mar.–Apr.).PubMedCrossRef

Greenberg, D., & Rankin, H. (1982). Compulsive gamblers in treatment. British Journal of Psychiatry, 140, 364–366 (Apr.).PubMed

Grimes, D. A., & Schulz, K. F. (2002a). An overview of clinical research: The lay of the land. Lancet, 359(9300), 57–61 (Jan. 5).PubMedCrossRef

Grimes, D. A., & Schulz, K. F. (2002b). Descriptive studies: What they can and cannot do. Lancet, 359(9301), 145–149 (Jan. 12).PubMedCrossRef

Hahn, R. (1997). The nocebo phenomenon: Concept, evidence, and implications for public health. Preventive Medicine, 26(5 Pt 1), 607–611 (Sep.–Oct.).PubMedCrossRef

Harbour, R., & Miller, J. (2001). A new system for grading recommendations in evidence based guidelines. British Medical Journal, 323, 334–336.PubMedCrossRef

Hodgins, D. C., Currie, S. R., & el-Guebaly, N. (2001). Motivational enhancement and self-help treatments for problem gambling. Journal of Consulting and Clinical Psychology, 69(1), 50–57 (Feb.).PubMedCrossRef

Hoffman, J. R. (1999). Rethinking case reports. Western Journal of Medicine, 170(5), 253–254 (May).PubMed

Hollander, E., Pallanti, S., Allen, A., Sood, E., & Baldini Rossi, N. (2005). Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? American Journal of Psychiatry, 162(1), 137–145 (Jan.).PubMedCrossRef

Hyland, M. E. (2003). Using the placebo response in clinical practice. Clinical Medicine, 3(4), 347–350 (Jul.–Aug.).PubMed

Ioannidis, J. P., Haidich, A. B., Pappa, M., Pantazis, N., Kokori, S. I., Tektonidou, M. G., et al. (2001). Comparison of evidence of treatment effects in randomized and nonrandomized studies. Journal of American Medical Association, 286(7), 821–830 (Aug. 15).CrossRef

Juni, P., Altman, D. G., & Egger, M. (2001a). Systematic reviews in health care: Assessing the quality of controlled clinical trials. British Medical Journal, 323(7303), 42–46 (Jul. 7).PubMedCrossRef

Juni, P., Altman, D. G., & Egger, M. (2001b). Assessing the quality of controlled clinical trials. In M. Egger, G. Davey Smith & D. G. Altman (Eds.), Systematic reviews in health care: Meta-analysis in context, 2nd edn. London: BMJ.

Kaptchuk, T. J. (2002). The placebo effect in alternative medicine: Can the performance of a healing ritual have clinical significance? Annuals of Internal Medicine, 136(11), 817–825 (Jun 4).

Kennedy, K. A., & Frankowski, R. F. (2003). Evaluating the evidence about therapies. What the clinician needs to know about statistics. Clinical Perinatology, 30(2), 205–215 (Jun.).CrossRef

Kim, S. W., Grant, J. E., Adson, D. E., & Shin, Y. C. (2001). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biological Psychiatry, 49(11), 914–921 (Jun. 1).PubMedCrossRef

Ladouceur, R.,Gosselin, P., LaBerge, M., & Blaszczynski, A. (2001a) Drop-outs in clinical research: Do results reported in field of addiction reflect clinical reality? The Behavioral Therapist, 24, 44–46.

Ladouceur, R., Sylvain, C., Boutin, C., Lachance, S., Doucet, C., Leblond, J., et al. (2001b). Cognitive treatment of pathological gambling. Journal of Nervous and Mental Disease, 189(11), 774–780 (Nov.).PubMedCrossRef

Ladouceur, R., Sylvain, C., Boutin, C., Lachance, S., Doucet, C., & Leblond, J. (2003). Group therapy for pathological gamblers: A cognitive approach. Behavior Research and Therapy, 41(5), 587–596 (May).CrossRef

Leblond, J., Ladouceur, R., & Blaszczynski, A. (2003). Which pathological gamblers will complete treatment? British Journal of Clinical Psychology, 42(Pt 2), 205–209 (Jun.).PubMedCrossRef

Lopez Viets, V. C., & Miller, W. R. (1997). Treatment approaches for pathological gamblers. Clinical Psychology Review, 17(7), 689–702 (Nov.).PubMedCrossRef

Macedo, A., Farre, M., & Banos, J. E. (2003). Placebo effect and placebos: What are we talking about? Some conceptual and historical considerations. European Journal of Clinical Pharmacology, 59(4), 337–342. Epub 2003 (Jun. 27, Aug.).PubMedCrossRef

Moher, D., Altman, D. G., Schulz, K. F., & Elbourne, D. R. (2004). Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond. Canadian Medical Association Journal, 171(4), 349–350 (Aug. 17).PubMedCrossRef

Moher, D., Schulz, K. F., & Altman, D. G., for the CONSORT Group (2001). The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet, 357, 1191–1194.PubMedCrossRef

Moeller, F. G., Dougherty, D. M., Barratt, E. S., Schmitz, J. M., Swann, A. C., & Grabowski, J. (2001). The impact of impulsivity on cocaine use and retention in treatment. Journal of Substance Abuse Treatment, 21(4), 193–198 (Dec.).PubMedCrossRef

Montori, V. M., Bhandari, M., Devereaux, P. J., Manns, B. J., Ghali, W. A., & Guyatt, G. H. (2002). In the dark: The reporting of blinding status in randomized controlled trials. Journal of Clinical Epidemiology, 55(8), 787–790 (Aug.).PubMedCrossRef

National Responsible Gambling Program (2005). Annual Report 2004. Available at: http://www. responsiblegambling.co.za, accessed on 9/7/05.

Oakley-Browne, M. A., Adams, P., & Mobberley, P. M. (2000). Interventions for pathological gambling. Cochrane Database Systematic Reviews, (2), CD001521.

Oh, V. M. (1991). Magic or medicine? Clinical pharmacological basis of placebo medication. Annuals Academy Medicine Singapore, 20(1), 31–37 (Jan.).

Papakostas, Y. G., & Daras, M. D. (2001). Placebos, placebo effect, and the response to the healing situation: The evolution of a concept. Epilepsia, 42(12), 1614–1625 (Dec.).PubMedCrossRef

Petry, N. M. (2005). Stages of change in treatment-seeking pathological gamblers. Journal of Consulting and Clinical Psychology, 73(2), 312–322 (Apr.).PubMedCrossRef

Petry, N. M., Stinson, F. S., & Grant, B. F. (2005). Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: Results from the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry, 66(5), 564–574 (May).PubMed

Reeves, B. C. (2004). Reasons for caution when evaluating health care interventions using non-randomised study designs. Forsch Komplementarmed Klass Naturheilkd, 11(Suppl 1), 40–45 (Aug.).PubMedCrossRef

Robson, E., Edwards, J., Smith, G., & Colman, I. (2002). Gambling decisions: An early intervention program for problem gamblers. Journal of Gambling Studies, 18(3), 235–255 (Fall).PubMedCrossRef

Rockloff, M. J., & Schofield, G. (2004). Factor analysis of barriers to treatment for problem gambling. Journal of Gambling Studies, 20(2), 121–126.PubMedCrossRef

Sackett, D. L., & Gent, M. (1979). Controversy in counting and attributing events in clinical trials. New England Journal of Medicine, 301(26), 1410–1412 (Dec. 27).PubMedCrossRef

Sackett, D. L., Richarson, W. S., Rosenberg, W., & Haynes, R. B. (1998). Evidence based medicine how to practice and teach EBM. Edinburgh, Scotland: Churchill Livingstone.

Saiz-Ruiz, J., Blanco, C., Ibanez, A., Masramon, X., Gomez, M. M., Madrigal, M., et al. (2005). Sertraline treatment of pathological gambling: A pilot study. Journal of Clinical Psychiatry, 66(1), 28–33 (Jan.).PubMedCrossRef

Schulz, K. F., Chalmers, I., Hayes, R. J., & Altman, D. G. (1995). Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of American Medical Association, 273, 408–412.CrossRef

Shaffer, H. J., Labrie, R. A., Laplante, D. A., Kidman, R. C., & Donato, A. N. (2005). The Iowa gambling treatment program: Treatment outcomes for a follow-up sample. Journal of Gambling Studies, 21(1), 59–71 (Spring).PubMedCrossRef

Shepherd, M. (1993). The placebo: From specificity to the non-specific and back. Psychological Medicine, 23(3), 569–578 (Aug.).PubMedCrossRef

Sibbald, B., & Roland, M. (1998). Understanding controlled trials. Why are randomised controlled trials important? British Medical Journal, 316(7126), 201 (Jan 17).PubMed

Stewart, R. M., & Brown, R. I. (1988). An outcome study of Gamblers Anonymous. British Journal of Psychiatry, 152, 284–288 (Feb.).PubMedCrossRef

Stinchfield, R., & Winters, K. C. (2001). Outcome of Minnesota’s gambling treatment programs. Journal of Gambling Studies, 17(3), 217–245 (Fall).PubMedCrossRef

Stone, D. A., Kerr, C. E., Jacobson, E., Conboy, L. A., & Kaptchuk, T. J. (2005). Patient expectations in placebo-controlled randomized clinical trials. Journal Evaluation of Clinical Practice, 11(1), 77–84 (Feb.).CrossRef

Straus, J. L., & von Ammon Cavanaugh, S. (1996). Placebo effects. Issues for clinical practice in psychiatry and medicine. Psychosomatics, 37(4), 315–326 (Jul–Aug.).PubMed

Toneatto, T., & Ladouceur, R. (2003). Treatment of pathological gambling: A critical review of the literature. Psychology of Addictive Behaviors, 42, 92–99.

Toneatto, T., & Millar, G. (2004). Assessing and treating problem gambling: Empirical status and promising trends. Canadian Journal of Psychiatry, 49(8), 517–525 (Aug.).

Vandenbroucke, J. P. (2001). In defense of case reports and case series. Annuals of Internal Medicine, 134(4), 330–334 (Feb 20).

Walker, M. B. (1992). The psychology of gambling. Oxford, England: Pergamon.

Walach, H., & Jonas, W. B. (2004). Placebo research: The evidence base for harnessing self-healing capacities. Journal of Alternative and Complementary Medicine, 10(Suppl 1), S103–S112.

Welte, J., Barnes, G., Wieczorek, W., Tidwell, M. C., & Parker, J. (2001). Alcohol and gambling pathology among U.S. adults: Prevalence, demographic patterns and comorbidity. Journal of Studies of Alcoholism, 62(5), 706–712 (Sep.).

Zlowodzki, M., Jonsson, A., & Bhandari, M. (2006). Common pitfalls in the conduct of clinical research. Medical Principles and Practices, 15(1), 1–8.CrossRef

Titel: Are the Effects of Gambling Treatment Overestimated?
verfasst von: James R. Westphal
Publikationsdatum: 01.01.2007
Verlag: Springer-Verlag
Erschienen in: International Journal of Mental Health and Addiction / Ausgabe 1/2007
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882
DOI: https://doi.org/10.1007/s11469-006-9038-4

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2007

Perceived Social Support, Coping Strategies and Alcohol Use among Rural Adolescents/USA Sample

Exercise Addiction in British Sport Science Students

Positive Thinking Among Slot Machine Gamblers: A Case of Maladaptive Coping?

Needs and Gaps Analysis: Problem Gambling Interventions Among New Zealand Asian Peoples